双侧胸廓内动脉至左冠系统后,右冠系统最佳补充移植血管是什么?一项荟萃分析
该荟萃分析比较动脉 conduit(AC)与大隐静脉(GSV)作为第三支血管行右冠系统血运重建的长期效果,纳入10项研究共4121例患者。汇总分析未显示AC与GSV在长期死亡率上有显著差异(HR=0.75,95%CI 0.56-1.01;P=0.061),但排除一项离群研究后AC显著降低长期死亡率(HR=0.67,95%CI 0.54-0.83;P<0.001)。倾向性匹配研究排除离群值后亦支持AC(HR=0.58,95%CI 0.43-0.80;P<0.001)。
要点
- 汇总分析未显示动脉 conduit 与大隐静脉在长期死亡率有显著差异。
- 排除一项离群研究后,动脉 conduit 显著降低长期死亡率。
- 倾向性匹配研究排除离群值后仍支持动脉 conduit 的长期生存优势。
核心结论
- 在双侧胸廓内动脉至左冠系统的基础上,选择第三支动脉 conduit 可能更有利于长期生存。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed和OVID MEDLINE 2000年1月至2017年9月相关文献。
- 共纳入10项研究、4121例患者,比较动脉 conduit(1619例)与大隐静脉(2502例)。
- 其中6项研究(2548例)比较大隐静脉与右胃网膜动脉(1023例),5项研究比较大隐静脉与桡动脉(596例)。
主要发现
- 汇总分析未显示动脉 conduit 与大隐静脉在长期死亡率上有显著差异(HR=0.75,95%CI 0.56-1.01;P=0.061)。
- 排除一项离群研究后,动脉 conduit 与更低的长期死亡率显著相关(HR=0.67,95%CI 0.54-0.83;P<0.001)。
- 6项倾向性匹配研究汇总分析未显示差异(HR=0.69,95%CI 0.43-1.08;P=0.107),排除离群值后动脉 conduit 显著降低长期死亡率(HR=0.58,95%CI 0.43-0.80;P<0.001)。
- 4项非倾向性匹配研究汇总分析未显示差异(HR=0.88,95%CI 0.62-1.23;P=0.438)。
- 大隐静脉与右胃网膜动脉或桡动脉的比较显示相似结果,未发现发表偏倚。
临床怎么用
- 在双侧胸廓内动脉至左冠系统的患者中,可优先考虑使用第三支动脉 conduit 行右冠系统血运重建以改善长期生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This meta-analysis was designed to assess the effect of the use of arterial conduits (ACs) versus great saphenous vein (GSV) grafts as a third conduit for revascularization of the right coronary artery system, in addition to the bilateral internal mammary artery on the left coronary artery. PubMed and OVID's version of MEDLINE were searched from January 2000 to September 2017 for relevant publications. The primary end point was the long-term mortality rate. The secondary end point was early mortality, defined as either in-hospital death or death within 30 days after the operation. Meta-regression was used to evaluate the effect of female gender and diabetes on the primary and secondary outcomes. A total of 10 studies (4121 patients) were selected for the systematic review and meta-analysis comparing ACs (1619) versus the GSV (2502), 6 (2548) comparing the GSV (2548) versus the right gastroepiploic artery (1023) and 5 comparing the GSV (2548) versus the radial artery (596). The pooled analysis did not show any difference between ACs and the GSV in terms of long-term mortality rates [hazard ratio (HR) = 0.75, 95% confidence interval (CI) = 0.56-1.01; P = 0.061]. When using the leave-one-out analysis, after the exclusion of 1 study (outlier), ACs were significantly associated with lower long-term mortality rates (HR = 0.67, 95% CI = 0.54-0.83; P < 0.001). When the results were stratified according to the type of study, no differences with regard to long-term results were found between ACs and the GSV, either in the pooled analysis of the 6 propensity score-matched studies (HR = 0.69, 95% CI = 0.43-1.08; P = 0.107) or in the pooled analysis of the 4 non-propensity score-matched studies (HR = 0.88, 95% CI = 0.62-1.23; P = 0.438). Again, when the outlier was excluded, the pooled analysis of the propensity score-matched studies confirmed that ACs were associated with lower long-term mortality rates (HR = 0.58, 95% CI = 0.43-0.80; P < 0.001). Comparisons between the GSV and either the right gastroepiploic artery or the radial artery showed similar results. No publication bias was found. This meta-analysis is the first to compare the GSV to the radial artery and the right gastroepiploic artery for right coronary artery grafting in patients receiving a bilateral internal mammary artery to left coronary artery. The choice of a third AC seems to be preferable in order to achieve better long-term survival.
引用
- Di Mauro M, Lorusso R, Di Franco A, et al. What is the best graft to supplement the bilateral internal thoracic artery to the left coronary system? A meta-analysis. Eur J Cardiothorac Surg. 2019. PMID: 30649244. doi:10.1093/ejcts/ezy476
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。